Myers T J, McGee M G, Zeluff B J, Radovancevic B, Frazier O H
Cullen Cardiovascular Research Laboratories, Texas Heart Institute, Houstin 77225-0345.
ASAIO Trans. 1991 Jul-Sep;37(3):M283-5.
Infections in patients undergoing mechanical circulatory support as a bridge to transplant are associated with significant mortality and morbidity. To determine the frequency and effects of infection during such procedures, a retrospective analysis was done of 14 patients who received prolonged (greater than 14 days) support with the Heartmate left ventricular assist device (LVAD) (Thermo Cardiosystems, Inc., Woburn, MA). All patients were men (mean age, 44.3 years), and duration of LVAD support ranged from 19 to 233 days (mean, 98.1 days). During LVAD support, five patients had no infections, and, in the remaining nine patients, infections were most common in the respiratory tract, catheter tips, and urine. Four device related infections occurred in three patients, all of which were resolved with antibiotic therapy. All 14 patients underwent transplantations, and none of the operations was delayed because of infection. Eleven of the patients are long-term survivors (range of time after transplant, 7.5-37 months). Infections were not associated with mortality or significant morbidity in this group of patients.
接受机械循环支持作为移植桥梁的患者发生感染,与显著的死亡率和发病率相关。为了确定此类手术期间感染的发生率和影响,对14例接受Heartmate左心室辅助装置(LVAD)(美国马萨诸塞州沃本市的热控心血管系统公司)长期(超过14天)支持的患者进行了回顾性分析。所有患者均为男性(平均年龄44.3岁),LVAD支持时间为19至233天(平均98.1天)。在LVAD支持期间,5例患者未发生感染,其余9例患者中,感染最常见于呼吸道、导管尖端和尿液。3例患者发生了4次与装置相关的感染,所有感染均通过抗生素治疗得到解决。14例患者均接受了移植手术,且没有一例手术因感染而延迟。11例患者为长期存活者(移植后时间范围为7.5至37个月)。在这组患者中,感染与死亡率或显著的发病率无关。